KR20090122469A - 정제된 리포펩티드의 제조 방법 - Google Patents

정제된 리포펩티드의 제조 방법 Download PDF

Info

Publication number
KR20090122469A
KR20090122469A KR1020097020735A KR20097020735A KR20090122469A KR 20090122469 A KR20090122469 A KR 20090122469A KR 1020097020735 A KR1020097020735 A KR 1020097020735A KR 20097020735 A KR20097020735 A KR 20097020735A KR 20090122469 A KR20090122469 A KR 20090122469A
Authority
KR
South Korea
Prior art keywords
crystalline
daptomycin
lipopeptides
lipopeptide
crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097020735A
Other languages
English (en)
Korean (ko)
Inventor
데니스 키이스
장-지 라이
찬드리카 고바르드한
나자르 칼라프
Original Assignee
큐비스트 파마슈티컬즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20090122469(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 큐비스트 파마슈티컬즈 인코포레이티드 filed Critical 큐비스트 파마슈티컬즈 인코포레이티드
Publication of KR20090122469A publication Critical patent/KR20090122469A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020097020735A 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법 Ceased KR20090122469A (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US25626800P 2000-12-18 2000-12-18
US60/256,268 2000-12-18
US27474101P 2001-03-09 2001-03-09
US60/274,741 2001-03-09
US34052501P 2001-12-13 2001-12-13
US34131501P 2001-12-13 2001-12-13
US60/340,525 2001-12-13
US60/341,315 2001-12-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7008117A Division KR20030081353A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020117023192A Division KR20110127732A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법

Publications (1)

Publication Number Publication Date
KR20090122469A true KR20090122469A (ko) 2009-11-30

Family

ID=27500563

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020097020735A Ceased KR20090122469A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법
KR1020117023192A Ceased KR20110127732A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법
KR1020087007405A Withdrawn KR20080036661A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법
KR10-2003-7008117A Ceased KR20030081353A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020117023192A Ceased KR20110127732A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법
KR1020087007405A Withdrawn KR20080036661A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법
KR10-2003-7008117A Ceased KR20030081353A (ko) 2000-12-18 2001-12-17 정제된 리포펩티드의 제조 방법

Country Status (12)

Country Link
US (2) US20030045678A1 (cg-RX-API-DMAC7.html)
EP (3) EP1343811A4 (cg-RX-API-DMAC7.html)
JP (2) JP2004525108A (cg-RX-API-DMAC7.html)
KR (4) KR20090122469A (cg-RX-API-DMAC7.html)
CN (3) CN1592753A (cg-RX-API-DMAC7.html)
AT (1) ATE535539T1 (cg-RX-API-DMAC7.html)
AU (3) AU2002246687C1 (cg-RX-API-DMAC7.html)
CA (1) CA2432096A1 (cg-RX-API-DMAC7.html)
ES (2) ES2691680T3 (cg-RX-API-DMAC7.html)
IL (3) IL156394A0 (cg-RX-API-DMAC7.html)
NZ (2) NZ571597A (cg-RX-API-DMAC7.html)
WO (1) WO2002056829A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101151878B1 (ko) * 2010-06-08 2012-05-31 미원상사주식회사 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물
WO2013012101A1 (ko) * 2011-07-15 2013-01-24 미원상사주식회사 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
WO2003099217A2 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
AU2003240545A1 (en) 2002-06-06 2003-12-22 Therapeutics Corporation Genome Use of ramoplanin to treat diseases associated with the use of antibiotics
JP2006515294A (ja) * 2002-12-12 2006-05-25 アクティブバイオティクス インコーポレイティッド アテローム性動脈硬化症およびその関連疾患を治療または予防するための方法および試薬
WO2004054513A2 (en) * 2002-12-12 2004-07-01 Activbiotics, Inc. Methods and compositions for treating and preventing ear infections
US7267624B2 (en) * 2004-07-30 2007-09-11 Acushnet Company Golf ball dimple pattern
BRPI0714391A2 (pt) * 2006-07-20 2013-04-24 Sicor Inc processo para preparaÇço de um ingrediente farmacÊutico ativo sàlido estÉril
WO2009144739A1 (en) * 2008-05-26 2009-12-03 Biocon Limited Amorphous daptomycin and a method of purification thereof
HRP20150761T4 (hr) * 2009-02-19 2021-08-06 Xellia Pharmaceuticals Aps Postupak za pročišćavanje lipopeptida
CN101830970B (zh) * 2009-03-12 2012-06-27 成都雅途生物技术有限公司 一种高纯度达托霉素(Daptomycin)的纯化制备方法
CN101899094B (zh) * 2009-06-01 2012-11-21 安徽丰原发酵技术工程研究有限公司 一种高纯达托霉素的制备方法
CA2781666C (en) * 2009-11-23 2017-02-21 Cubist Pharmaceuticals, Inc. Lipopeptide compositions and related methods
EP2504020A4 (en) * 2009-11-23 2013-05-29 Eagle Pharmaceuticals Inc Daptomycin FORMULATIONS
CN102276696B (zh) * 2010-06-09 2014-11-05 上海来益生物药物研究开发中心有限责任公司 达托霉素的纯化方法
CA2823628A1 (en) 2011-01-05 2012-07-12 Hospira, Inc. Spray drying vancomycin
KR101034663B1 (ko) * 2011-03-18 2011-05-17 김태욱 손목 피로를 저감시키는 마우스
CN102206694B (zh) * 2011-04-06 2013-10-16 山东新时代药业有限公司 一种含有癸酸的缓释组合物
MX2013013760A (es) * 2011-05-26 2014-01-08 Cubist Pharm Inc Composiciones de cb-183, 315 y metodos relacionados.
CN102241732B (zh) * 2011-05-30 2015-01-21 浙江海正药业股份有限公司 一种脂肽化合物的纯化方法
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs
CN102875652A (zh) * 2011-07-13 2013-01-16 北大方正集团有限公司 一种分离纯化达托霉素的方法
CN102718839B (zh) * 2012-07-05 2017-05-24 鲁南新时代生物技术有限公司 一种分离纯化达托霉素的方法
WO2014031681A1 (en) * 2012-08-20 2014-02-27 The University Of Chicago Inhibiting gram positive bacteria
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
CN104387444B (zh) * 2014-11-13 2017-12-08 北大医药重庆大新药业股份有限公司 一种达托霉素杂质rs‑2高纯度样品的制备方法
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
CN109476704B (zh) * 2016-04-08 2022-08-16 港大科桥有限公司 抗菌环脂肽
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
IT201600127655A1 (it) 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
IT201800006314A1 (it) * 2018-06-14 2019-12-14 Uso di resine a scambio cationico per la purificazione di antibiotici lipopolipeptidici
WO2020086931A1 (en) * 2018-10-25 2020-04-30 Cidara Therapeutics, Inc. Polymorph of echinocandin antifungal agent
US12239685B2 (en) 2018-12-21 2025-03-04 Arecor Limited Composition
CN112979756B (zh) * 2019-12-13 2023-01-03 浙江昌海制药有限公司 达托霉素的提纯方法
CN113480623B (zh) * 2021-08-09 2022-12-27 广州天赐高新材料股份有限公司 一种脂肽组合物及其制备方法和应用
CN116726145A (zh) * 2022-03-04 2023-09-12 海南普利制药股份有限公司 一种稳定的酯肽类药物组合物
KR20250088544A (ko) * 2022-10-20 2025-06-17 추가이 세이야쿠 가부시키가이샤 고리형 펩티드 결정을 제조하는 방법
KR20250125378A (ko) * 2022-12-28 2025-08-21 추가이 세이야쿠 가부시키가이샤 고리형 펩타이드의 정제 방법 및 제조 방법

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1021538B (de) † 1954-06-04 1957-12-27 Bristol Lab Inc Verfahren zur Herstellung und Gewinnung einer antibiotisch wirkenden Verbindung
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
USRE31396E (en) * 1978-10-16 1983-09-27 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4812470A (en) 1982-02-27 1989-03-14 Beecham Group P.L.C. Antibacterial monic acid derivatives
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
FR2533209B1 (fr) * 1982-09-22 1985-11-08 Centre Nat Rech Scient Lipopeptides, leur obtention et leur application comme emulsifiants
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US4800157A (en) * 1985-09-09 1989-01-24 Eli Lilly And Company Process for producing the A-21978C antibiotics
EP0294990A3 (en) * 1987-06-10 1990-05-09 Eli Lilly And Company Chromatographic purification process
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4874843A (en) * 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
CA1337758C (en) * 1988-04-11 1995-12-19 Eli Lilly And Company Peptide antibiotics
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US4886243A (en) * 1988-10-26 1989-12-12 Trumbull Christopher J Hydraulic jack ramp
NZ232763A (en) * 1989-03-06 1991-09-25 Lilly Co Eli Parenteral formulation comprising daptomycin with a buffer to maintain ph between 6.0 and 8.0
US5202309A (en) 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
JPH04224197A (ja) * 1990-12-26 1992-08-13 Fujitsu Ltd 生体高分子結晶化方法および装置
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5336756A (en) * 1991-05-01 1994-08-09 Merck & Co., Inc. Process for crystalline cyclic lipopeptides
TW213468B (cg-RX-API-DMAC7.html) * 1991-06-29 1993-09-21 Hoechst Ag
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
ATE239431T1 (de) * 1992-10-21 2003-05-15 Gynetech Lab Inc Abgabesystem bestehend aus einem vaginaschwamm
EP0712405A1 (en) 1993-08-13 1996-05-22 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US5716960A (en) * 1995-01-13 1998-02-10 U.S. Bioscience Inc. And Individuals Crystalline trimetrexate salts and the process for making the same
JP3067972B2 (ja) * 1995-03-03 2000-07-24 新日本理化株式会社 ジアセタールの六方晶結晶、該六方晶結晶を含む核剤、該六方晶結晶を含むポリオレフィン系樹脂組成物及び成形物、並びに該組成物の成形方法
CN1087288C (zh) * 1995-07-17 2002-07-10 沃尼尔·朗伯公司 结晶[R－(R*,R*)]－2－(4－氟苯基)－β,δ－二羟基－5－(1－甲基乙基)－3－苯基－4－[(苯氨基)羰基]－1H－吡咯－1－庚酸半钙盐
DE19546573A1 (de) * 1995-12-13 1997-06-19 Uetikon Chemie Gmbh Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5972331A (en) * 1995-12-22 1999-10-26 Schering Corporation Crystalline interferon alpha for pulmonary delivery and method for producing the same
JP4711471B2 (ja) * 1996-07-05 2011-06-29 三菱商事フードテック株式会社 結晶マルチトール及びそれを含有する含蜜結晶の製造方法
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
US5928666A (en) * 1996-11-12 1999-07-27 Cygnus Inc. Crystalline form of estradiol and pharmaceutical formulations comprising same
JP3569422B2 (ja) * 1996-12-26 2004-09-22 シャープ株式会社 結晶型オキソチタニルフタロシアニン及びそれを用いた電子写真感光体並びに画像形成方法
US6017562A (en) * 1997-04-28 2000-01-25 Arch Chemicals, Inc. Non-spherical and non-platelet crystalline forms of pyrithione salts
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
WO1999042191A1 (en) * 1998-02-18 1999-08-26 Biospace International Inc. Dynamically controlled crystallization method and apparatus and crystals obtained thereby
DE19807972A1 (de) † 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
AU5331199A (en) 1998-08-07 2000-02-28 Merck & Co., Inc. Method for the production of an antibiotic agent
WO2000018419A2 (en) * 1998-09-25 2000-04-06 Cubist Pharmaceuticals, Inc. Methods for administration of antibiotics
KR20020063230A (ko) 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서의 신규한 리포펩티드
CA2393907A1 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals Inc. Novel lipopeptides as antibacterial agents
AU784812B2 (en) 1999-12-15 2006-06-29 Merck Sharp & Dohme Corp. Lipopeptides as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
WO2002059145A1 (en) † 2000-12-18 2002-08-01 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
US9394340B2 (en) † 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101151878B1 (ko) * 2010-06-08 2012-05-31 미원상사주식회사 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물
WO2013012101A1 (ko) * 2011-07-15 2013-01-24 미원상사주식회사 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물

Also Published As

Publication number Publication date
WO2002056829A2 (en) 2002-07-25
EP1908770B2 (en) 2015-07-15
KR20110127732A (ko) 2011-11-25
JP4927003B2 (ja) 2012-05-09
AU2002246687B2 (en) 2008-05-29
NZ571597A (en) 2010-05-28
EP1343811A4 (en) 2004-12-08
ES2377931T3 (es) 2012-04-03
US20030045678A1 (en) 2003-03-06
CN1982330B (zh) 2012-01-25
US20030045484A1 (en) 2003-03-06
IL230244A (en) 2017-12-31
AU2002246687B8 (en) 2008-10-02
JP2004525108A (ja) 2004-08-19
IL156394A0 (en) 2004-01-04
HK1108582A1 (en) 2008-05-09
KR20030081353A (ko) 2003-10-17
AU2002246687C1 (en) 2009-11-05
CN1592753A (zh) 2005-03-09
AU2008207496B2 (en) 2012-06-14
AU2002246688A1 (en) 2002-07-30
AU2008207496A1 (en) 2008-09-11
EP2261237A2 (en) 2010-12-15
CA2432096A1 (en) 2002-08-01
CN102070703A (zh) 2011-05-25
EP1908770A1 (en) 2008-04-09
NZ554405A (en) 2009-04-30
JP2008214348A (ja) 2008-09-18
CN102070703B (zh) 2014-08-06
EP1343811A1 (en) 2003-09-17
ES2377931T5 (es) 2015-11-04
WO2002056829A3 (en) 2003-03-27
ATE535539T1 (de) 2011-12-15
EP1908770B1 (en) 2011-11-30
EP2261237A3 (en) 2011-01-26
ES2691680T3 (es) 2018-11-28
EP2261237B1 (en) 2018-08-22
CN1982330A (zh) 2007-06-20
IL156394A (en) 2015-05-31
KR20080036661A (ko) 2008-04-28

Similar Documents

Publication Publication Date Title
JP4927003B2 (ja) 精製リポペプチドの調製方法
US8697638B2 (en) Methods for preparing purified lipopeptides
AU2002246687A1 (en) Methods for preparing purified lipopeptides
JP5303087B2 (ja) 高純度リポペプチド、リポペプチドミセルおよびこれらを調製するための処理
WO2002059145A1 (en) Methods for preparing purified lipopeptides
HK1108582B (zh) 制备纯化脂肽的方法
HK1150615A (en) Daptomycin and related analogs in crystalline form, their preparation and use

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20091001

A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20091102

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100113

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20110730

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20100113

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20110831

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20110730

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20130128

Appeal identifier: 2011101006273

Request date: 20110831

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20110930

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20110831

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20110831

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20101115

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20091102

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20111103

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20110831

Effective date: 20130128

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20130128

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20110831

Decision date: 20130128

Appeal identifier: 2011101006273